Carsten Brunn - Nov 13, 2023 Form 4 Insider Report for Cartesian Therapeutics, Inc. (SELB)

Role
President and CEO, Director
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Carsten Brunn
Stock symbol
SELB
Transactions as of
Nov 13, 2023
Transactions value $
-$2,383,268
Form type
4
Date filed
11/15/2023, 05:26 PM
Previous filing
Sep 26, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SELB Common Stock Disposed to Issuer -$113K -55K -7.02% $2.06 728K Nov 13, 2023 Direct F1
transaction SELB Common Stock Disposed to Issuer -$28K -13.6K -1.87% $2.06 714K Nov 13, 2023 Direct F2
transaction SELB Common Stock Disposed to Issuer -$350K -170K -23.76% $2.06 545K Nov 13, 2023 Direct F3
transaction SELB Common Stock Disposed to Issuer -$583K -283K -51.91% $2.06 262K Nov 13, 2023 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SELB Employee Stock Option (right to buy) Disposed to Issuer -1M -100% 0 Nov 13, 2023 Common Stock 1M $6.03 Direct F5
transaction SELB Employee Stock Option (right to buy) Disposed to Issuer -330K -100% 0 Nov 13, 2023 Common Stock 330K $2.20 Direct F6
transaction SELB Employee Stock Option (right to buy) Disposed to Issuer -$124K -400K -100% $0.31 0 Nov 13, 2023 Common Stock 400K $1.75 Direct F7
transaction SELB Employee Stock Option (right to buy) Disposed to Issuer -600K -100% 0 Nov 13, 2023 Common Stock 600K $2.30 Direct F8
transaction SELB Employee Stock Option (right to buy) Disposed to Issuer -75K -100% 0 Nov 13, 2023 Common Stock 75K $2.84 Direct F9
transaction SELB Employee Stock Option (right to buy) Disposed to Issuer -670K -100% 0 Nov 13, 2023 Common Stock 670K $2.99 Direct F10
transaction SELB Employee Stock Option (right to buy) Disposed to Issuer -163K -100% 0 Nov 13, 2023 Common Stock 163K $4.32 Direct F11
transaction SELB Employee Stock Option (right to buy) Disposed to Issuer -1.06M -100% 0 Nov 13, 2023 Common Stock 1.06M $3.31 Direct F12
transaction SELB Employee Stock Option (right to buy) Disposed to Issuer -$1.19M -1.28M -100% $0.93 0 Nov 13, 2023 Common Stock 1.28M $1.13 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This unvested restricted stock, which was granted on January 4, 2021, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc., in exchange for $113,300, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
F2 This unvested restricted stock, which was granted on September 24, 2021, was canceled in the Merger, in exchange for $28,016, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
F3 This unvested restricted stock, which was granted on January 3, 2022, was canceled in the Merger, in exchange for $349,633.50, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
F4 This unvested restricted stock, which was granted on January 2, 2023, was canceled in the Merger, in exchange for $582,568, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
F5 This option, which provided for vesting as to 25% of the shares on December 1, 2019 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
F6 This option, which provided for vesting as to 25% of the shares on February 25, 2020 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
F7 This option, which provided for vesting as to 50% of the shares on October 7, 2020 and the remaining 50% of the shares on October 7, 2021, was canceled in the Merger, in exchange for a cash payment of $124,000, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
F8 This option, which provided for vesting as to 25% of the shares on January 2, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
F9 This option, which provided for vesting as to 25% of the shares on July 1, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
F10 This option, which provided for vesting as to 25% of the shares on January 4, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
F11 This option, which provided for vesting as to 25% of the shares on September 24, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
F12 This option, which provided for vesting as to 25% of the shares on January 3, 2023 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
F13 This option, which provided for vesting as to 25% of the shares on January 2, 2024 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger, in exchange for a cash payment of $1,185,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.